Основная статистика
| CIK | 1092534 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to AVVAA World Health Care Products, Inc.
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| May 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 28, 2021 Date of Report (Date of earliest event reported) AVVAA World Health Care Products, Inc. (Exact name of registrant as specified in its charter) Nevada 000-301611 88-395714 (State or other jurisdiction of incorporation or |
|
| May 28, 2021 | ||
| March 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 18, 2020 Date of Report (Date of earliest event reported) AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-31611 88-395714 (State or other jurisdiction of incorporation or |
|
| March 16, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 13, 2020 Date of Report (Date of earliest event reported) AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-31611 88-395714 (State or other jurisdiction of incorporation or |
|
| March 12, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 20, 2020 Date of Report (Date of earliest event reported) AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 000-31611 88-395714 (State or other jurisdiction of incorporation |
|
| January 16, 2009 |
15-12G/A 1 f11512ga1avva.htm CERTIFICATION AND NOTICE OF TERMINATION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15/A CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-3 |
|
| January 11, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-31611 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant a |
|
| November 20, 2007 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2007 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-26715 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of regist |
|
| November 2, 2007 |
AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS Introduction AVVAA World Health Care Products, Inc. (the “Company”) has adopted this Code of Ethics for its senior financial management to promote honest and ethical conduct and to deter wrongdoing. This Code applies to the Company’s Chief Executive Officer and any Chief Financial Officer, treasurer, controller and other senior financial office |
|
| November 2, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2007 Commission File Number 0-31611 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 88-395714 (State or other jurisdiction of |
|
| November 2, 2007 |
10KSB 1 f10k0507avvaa.htm ANNUAL REPORT FOR THE PERIOD ENDING 05/07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2007 Commission File Number 0-31611 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) |
|
| November 1, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2007 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-31611 88-395714 (State or other jurisdiction of incorporation or |
|
| October 16, 2007 |
NT 10-Q 1 extf10qsb0807avvaa.htm FORM 10QSB EXTENSION FOR THE PERIOD ENDING 08/07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2009 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-50494 CUSIP NUMBER (Check one): o Form 10-K o Form 20-F o Form 11-K þ Form |
|
| September 5, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: April 30, 2009 Estimated average burden hours per response ... 2.50 SEC FILE NUMBER 000-31661 CUSIP NUMBER (Check one): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: May 31, 2007 o Trans |
|
| August 30, 2007 |
AMENDED SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ý Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to §240. |
|
| August 16, 2007 |
SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ý Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to §240. |
|
| May 10, 2007 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest reported): April 23, 2007 AVVAA WORLD HEALTH CARE PRODUCTS, INC. |
|
| April 16, 2007 |
10QSB 1 f10qsb022807avvaa.htm QUARTERLY REPORT FOR THE PERIOD ENDING 02/07 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2007 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission fil |
|
| January 16, 2007 |
10QSB 1 f10qsb1106avvaa.htm QUARTERLY REPORT FOR THE PERIOD ENDING 11/06 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2006 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file |
|
| November 30, 2006 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest reported): November 28, 2006 AVVAA WORLD HEALTH CARE PRODUCTS, INC. |
|
| October 16, 2006 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2006 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-26715 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of regist |
|
| October 5, 2006 |
AW 1 regwithdrawalavvaa.htm WITHDRAWAL OF AMEND NO. 1 OF REGISTRATION STATEMENT AVVAA WORLD HEALTH CARE PRODUCTS, INC. BOX 459, 1710 SHUSWAP AVE. LUMBY, BC, CANADA V0E 2G0 (250) 547-2048 October 5, 2006 Securities and Exchange Commission 450 Fifth Street, N.W. Judiciary Plaza Washington, D.C. 20549 Re: AVVAA World Health Care Products, Inc. Amendment No. 1 to Registration Statement on Form SB-2 Fi |
|
| October 5, 2006 |
SB-2/A 1 fsb2a1906iiavvaa.htm AMENDMENT NO. 1 TO REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on October 5, 2006 REGISTRATION NO. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Name of Small Business Issuer in its Charter) Nevada 327 |
|
| October 3, 2006 |
AVVAA WORLD HEALTH CARE PRODUCTS, INC. BOX 459, 1710 SHUSWAP AVE. LUMBY, BC, CANADA V0E 2G0 (250) 547-2048 October 3, 2006 U.S. Securities & Exchange Commission Office of Small Business 450 Fifth Street NW Washington, D.C. 20549 Re: AVVAA World Health Care Products, Inc. File No. 333-134321 Dear Sir/Madam: Request is hereby made for the acceleration of the effective date of our Registration Statem |
|
| October 3, 2006 |
October 3, 2006 Song P. Brandon, Esq. Securities and Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: AVVAA World Health Care Products, Inc. Registration Statement on Form SB-2 Filed May 19, 2006 File Number 333-134321 Dear Ms. Brandon: We represent AVVAA World Health Care Products, Inc. (“AVVAA”). We are in receipt of your letter dated May 30, 2006 regarding the above referenced |
|
| September 21, 2006 |
SB-2/A 1 fsb2a1906avvaa.htm AMENDMENT NO. 1 TO REGSITRATION STATEMENT As filed with the Securities and Exchange Commission on September 21, 2006 REGISTRATION NO. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM SB-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Name of Small Business Issuer in its Charter) Nevada 32 |
|
| September 14, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2006 Commission File Number 0-31611 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 88-395714 (State or other jurisdiction of incorporation or o |
|
| September 14, 2006 |
AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS Introduction AVVAA World Health Care Products, Inc. (the “Company”) has adopted this Code of Ethics for its senior financial management to promote honest and ethical conduct and to deter wrongdoing. This Code applies to the Company’s Chief Executive Officer and any Chief Financial Officer, treasurer, controller and other senior financial office |
|
| August 29, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For Period Ended: May 31, 2006 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transiti |
|
| July 18, 2006 |
EX-16 3 f8kamend1ex16avvaa.htm LETTER FROM ACCOUNTANT Exhibit 16.1 Re: AVVAA World Health Care Products, Inc. This letter will confirm that we reviewed Item 4.01 of the Company’s Amended Form 8-K dated July 18, 2006 captioned “Changes in Registrant’s Certifying Accountant” and that we agree with the statements made as they relate to Manning Elliott LLP. We are not in a position to agree or disagre |
|
| July 18, 2006 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 1, 2006 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) NEVADA 000-31611 88-395714 (STATE OR OTHER JURISDICTION OF INCORPORATION OR |
|
| July 18, 2006 |
July 18, 2006 Vanessa Robertson Securities and Exchange Commission Division of Corporate Finance Mail Stop 6010 Washington, D. |
|
| July 18, 2006 |
July 18, 2006 Vanessa Robertson Securities and Exchange Commission Division of Corporate Finance Mail Stop 6010 Washington, D. |
|
| June 30, 2006 |
DEF 14A 1 def14a063006avvaa.htm DEFINITIVESCHEDULE 14A SCHEDULE 14A INFORMATION AMENDMENT NO. 1 PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Pro |
|
| June 29, 2006 |
June 28, 2006 Song P. Brandon, Esq. Securities and Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: AVVAA World Health Care Products, Inc. Preliminary Proxy Statement on Schedule 14A File Number 0-31611 Dear Ms. Brandon: We represent AVVAA World Health Care Products, Inc. (“AVVAA”). We are in receipt of your letter dated June 20, 2006 regarding the above referenced filing and the |
|
| June 29, 2006 |
SCHEDULE 14A INFORMATION AMENDMENT NO. 1 PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: xPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Proxy Statement oDefinitive Additional Materials oSoliciti |
|
| June 16, 2006 |
PRE 14A 1 pre14a0606avvaa.htm PRELIMINARY SCHEDULE 14A SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: xPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Proxy Statement oDe |
|
| May 19, 2006 |
EX-10.19 6 fsb20506ex1019avvaa.htm FORM OF WARRANT THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN OR IN A SECURITIES PURCHASE AGREEMENT DATED AS OF MARCH 27, 2006, NEITHER THIS WARRANT NOR ANY OF SUCH SHARES MAY BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EF |
|
| May 19, 2006 |
NATIONAL FINANCIAL COMMUNICATIONS CORP. CONSULTING AGREEMENT EX-10.20 7 fsb20506ex1020avvaa.htm CONSULTING AGREEMENT WITH NATIONAL FINANCIAL NATIONAL FINANCIAL COMMUNICATIONS CORP. CONSULTING AGREEMENT AGREEMENT made as of the 1st day of May, 2006 by and AVVAA World Healthcare, maintaining its principal offices at 3018 Schaeffer Rd, Falkland, BC Canada V0E 1W0. (hereinafter referred to as “Client”) and National Financial Communications Corp. DBA/ OTC Financ |
|
| May 19, 2006 |
CALLABLE SECURED CONVERTIBLE NOTE EX-10.18 5 fsb20506ex1018avvaa.htm FORM OF CONVERTIBLE NOTE THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THE SECURITIES MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR AN OPINION OF COUNSEL IN FORM, SUBSTANCE AND SCOPE CUSTOMARY F |
|
| May 19, 2006 |
EX-10.17 4 fsb20506ex1017avvaa.htm SUBSCRIPTION AGREEMENT SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 30, 2006, by and among AVVAA World Healthcare Products, Inc., a Nevada corporation, with headquarters located at Box 459, 1710 Shuswap Ave., Lumby, BC, Canada V0E 2GO (the “Company”), and each of the purchasers set forth on the signature pages |
|
| May 19, 2006 |
As filed with the Securities and Exchange Commission on May 19, 2006 REGISTRATION NO. |
|
| May 9, 2006 |
8-K 1 f8k050106avvaa.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): May 1, 2006 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) NEVADA 000-31611 88-395714 (STATE OR OTHER JURISDICTION OF IN |
|
| April 19, 2006 |
10QSB 1 f10qsb0206avvaa.htm QUARTERLY REPORT FOR THE PERIOD ENDING 02/06 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2006 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file |
|
| April 5, 2006 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 - FORM 8-K - CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 31, 2006 AVVAA WORLD HEALTH CARE PRODUCTS INC. (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) Nevada 000-31611 88-0395714 (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION |
|
| March 10, 2006 |
C O N S U L T I N G A G R E E M E N T EX-4.1 2 fs8030906ex4avvaa.htm CONSULTING AGREEMENT C O N S U L T I N G A G R E E M E N T AGREEMENT made as of the 1st day of February 16 , 2006 between AVVAA World Healthcare., maintaining its principal offices at Box 459, 1710 Shuswap Ave Lumby, BC V0E 2G0, CN (hereinafter referred to as “Client”) and Richard DiCupua 4502 East Paradise Pkwy, suite 1039, Phoenix, AZ 85032 (hereinafter referred as |
|
| March 10, 2006 |
As filed with the Securities and Exchange Commission On March 9, 2006 Registration No. |
|
| January 23, 2006 |
10QSB 1 f10qsb1105avvaa.htm QUARTERLY REPORT FOR THE PERIOD ENDING 11/05 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2005 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file |
|
| January 17, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For Period Ended: November 30, 2005 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Tra |
|
| January 6, 2006 | ||
| January 6, 2006 | ||
| January 6, 2006 | ||
| January 6, 2006 | ||
| January 6, 2006 | ||
| January 6, 2006 | ||
| December 16, 2005 |
AVVAA WORLD HEALTH CARE PRODUCTS, INC. BOX 459, 1710 SHUSWAP AVE. LUMBY, BC, CANADA V0E 2G0 (250) 379-2727 December 16, 2005 U.S. Securities & Exchange Commission Office of Small Business 450 Fifth Street NW Washington, D.C. 20549 Re: AVVAA World Health Care Products, Inc. File No. 333-124667 Dear Sir/Madam: Request is hereby made for the acceleration of the effective date of our Registration Stat |
|
| October 27, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2004 Commission File Number 0-31611 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 88-395714 (State or other jurisdiction of |
|
| October 27, 2005 |
October 26, 2005 Zafar Hasan, Esq. Securities and Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: AVVAA World Health Care Products, Inc. Amendment No. 2 to Registration Statement on Form SB-2 Filed September 20, 2005 File Number 333-124667 Dear Mr. Hasan: We represent AVVAA World Health Care Products, Inc. (?AVVAA?). We are in receipt of your letter dated October 5, 2005 regardin |
|
| October 27, 2005 |
As filed with the Securities and Exchange Commission on October 26, 2005 REGISTRATION NO. |
|
| October 27, 2005 |
AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS EX-14 3 f10ksbex14avvaa.htm CODE OF ETHICS AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS Introduction AVVAA World Health Care Products, Inc. (the “Company”) has adopted this Code of Ethics for its senior financial management to promote honest and ethical conduct and to deter wrongdoing. This Code applies to the Company’s Chief Executive Officer and any Chief Financial Officer, treasurer, c |
|
| October 27, 2005 |
AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS Introduction AVVAA World Health Care Products, Inc. (the ?Company?) has adopted this Code of Ethics for its senior financial management to promote honest and ethical conduct and to deter wrongdoing. This Code applies to the Company?s Chief Executive Officer and any Chief Financial Officer, treasurer, controller and other senior financial office |
|
| October 27, 2005 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2005 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-26715 AVVAA WORLD HEALTH CARE PRODUCTS, INC. |
|
| October 27, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2005 Commission File Number 0-31611 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 88-395714 (State or other jurisdiction of |
|
| October 24, 2005 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2005 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-26715 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of regist |
|
| October 17, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For Period Ended: August 31, 2005 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Trans |
|
| September 21, 2005 |
September 20, 2005 Zafar Hasan, Esq. Securities and Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: AVVAA World Health Care Products, Inc. Amendment No. 1 to Registration Statement on Form SB-2 Filed June 20, 2005 File Number 333-124667 Dear Mr. Hasan: We represent AVVAA World Health Care Products, Inc. (“AVVAA”). We are in receipt of your letter dated July 11, 2005 regarding the |
|
| September 21, 2005 |
As filed with the Securities and Exchange Commission on September 20, 2005 REGISTRATION NO. |
|
| September 21, 2005 |
MODIFICATION AND AMENDMENT AGREEMENT EX-10.16 6 fsb2a2ex1016avvaa.htm MODIFICATION AND AMENDMENT AGREEMENT MODIFICATION AND AMENDMENT AGREEMENT This Modification and Amendment Agreement (“Agreement”) dated as of August 2, 2005 is entered into by and among AVVAA World Health Care Products, Inc., a Nevada corporation (the “Company”) and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subsc |
|
| September 19, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2004 Commission File Number 0-31611 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 88-395714 (State or other jurisdiction of |
|
| September 13, 2005 |
AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS EX-14 3 f10ksb2005ex14avvaa.htm CODE OF ETHICS AVVAA WORLD HEALTH CARE PRODUCTS, INC. CODE OF ETHICS Introduction AVVAA World Health Care Products, Inc. (the “Company”) have adopted this Code of Ethics for its senior financial management to promote honest and ethical conduct and to deter wrongdoing. This Code applies to the Company’s Chief Executive Officer and any Chief Financial Officer, treasur |
|
| September 13, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2005 Commission File Number 0-31611 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 88-395714 (State or other jurisdiction of incorporation or o |
|
| August 29, 2005 |
NT 10-K 1 extf10ksb2005avvaa.htm FORM 10K EXTENSION FOR YEAR END REPORT FOR 2005 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For Period Ended: May 31, 2005 [ ] Transition Report on Form 10-K [ |
|
| June 22, 2005 |
EX-10.15 52 fsb2a1ex1015avvaa.htm PROMISSORY NOTE TO SHIELD-TECH PRODUCTS, INC. Promissory Note $470,000.00US Falkland, BC, Canada May 31, 2002 For Value Received, the undersigned AVVAA World Healthcare Products of Falkland, BC, (jointly and severally, if more than one) promises to pay to Shield- Tech Products Inc. of Falkland, BC, the principal sum of Four hundred and seventy thousand dollars ($4 |
|
| June 22, 2005 | ||
| June 22, 2005 |
As filed with the Securities and Exchange Commission on May 5, 2005 REGISTRATION NO. |
|
| June 22, 2005 |
June 20, 2005 Zafar Hasan, Esq. Securities and Exchange Commission 450 Fifth Street, NW Washington, DC 20549 Re: AVVAA World Health Care Products, Inc. Registration Statement On Form SB-2 Filed May 5, 2005 File Number 333-124667 Dear Mr. Hasan: We represent AVVAA World Health Care Products, Inc. (?AVVAA?). We are in receipt of your letter dated June 2, 2005 regarding the above referenced filing an |
|
| June 22, 2005 | ||
| June 9, 2005 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2005 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-26715 AVVAA WORLD HEALTH CARE PRODUCTS, INC. |
|
| May 5, 2005 | ||
| May 5, 2005 |
CLASS C COMMON STOCK PURCHASE WARRANT EX-10.5 12 fsb2ex105avvaa.htm FORM OF CLASS C COMMON STOCK PURCHASE WARRANT THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION ST |
|
| May 5, 2005 |
CLASS B COMMON STOCK PURCHASE WARRANT EX-10.4 11 fsb2ex104avvaa.htm FORM OF CLASS B COMMON STOCK PURCHASE WARRANT THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION ST |
|
| May 5, 2005 |
CLASS A COMMON STOCK PURCHASE WARRANT EX-10.3 10 fsb2ex103avvaa.htm FORM OF CLASS A COMMON STOCK PURCHASE WARRANT THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION ST |
|
| May 5, 2005 |
As filed with the Securities and Exchange Commission on May 5, 2005 REGISTRATION NO. |
|
| May 5, 2005 |
AVVAA World Health Care Products, Inc. EX-4.1 5 fsb2ex41avvaa.htm 2005 STOCK OPTION AGREEMENT AVVAA World Health Care Products, Inc. 2005 STOCK OPTION PLAN Effective March 1, 2005 1. ARTICLE GENERAL PROVISIONS 1.1. PURPOSE OF THE PLAN This 2005 Stock Option Plan (the “Plan”) is intended to promote the interests of AVVAA World Health Care Products, Inc., a Nevada corporation (the “Corporation”), by providing eligible persons with the op |
|
| May 5, 2005 |
made as of the 6th day of May 2003. EX-10.7 14 fsb2ex107avvaa.htm JOHN FARLEY EMPLOYMENT AGREEMENT THIS AGREEMENT made as of the 6th day of May 2003. BETWEEN: AVVAA World Health Care Products a Company incorporated pursuant to the laws of the state of Nevada and having an office address located at 3018 Schaeffer Road, Falkland, British Columbia, V0E 1W0 (the “Employer”) AND: Mr. John S. Farley P.O. Box 335 3018 Schaeffer Rd. Falklan |
|
| May 5, 2005 |
EX-10.2 9 fsb2ex102avvaa.htm FORM OF CONVERTIBLE NOTE THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER |
|
| May 5, 2005 |
CONTRACT AVVAA WORLD HEALTH CARE PRODUCTS, INC CROSSFIRE NETWORK, INC. EX-10.10 17 fsb2ex1010avvaa.htm CROSSFIRE NETWORK, INC. AGREEMENT CONTRACT BETWEEN AVVAA WORLD HEALTH CARE PRODUCTS, INC AND CROSSFIRE NETWORK, INC. This Contract (“MPC”) is entered into this 20th day of January, 2005 between AVVAA World Health Care Product, Inc. (“AVVAA”) a Publicly listed, Nevada Corporation, using a correspondence address of P.O. Box 355, 3018 Schaeffer Rd. Falkland, BC, Canada |
|
| May 5, 2005 |
EX-10.9 16 fsb2ex109avvaa.htm DR. MARK ALDEN CONSULTING AGREEMENT CONSULTANT AND ADVISOR AGREEMENT Between AVVAA WORLD HEALTH CARE PRODUCTS INC. (the “Company”) PO Box 335, 3018 Schaeffer Road, Falkland, British Columbia, Canada, V0E 1W0 and; Dr. Mark Alden WHEREAS, Company has retained Consultant for the purpose of assisting the Company in the conduct of its business, including its world wide day |
|
| May 5, 2005 |
EX-10.12 26 fsb2ex1012avvaa.htm NATURES FORMULAE HEALTH PRODUCTS AGREEMENT MANUFACTURING AGREEMENT This Manufacturing Agreement (the “Agreement”) is made this day of August, 2004. BETWEEN: AVVAA WORLD HEALTH CARE PRODUCTS, INC. 3018 Schaeffer Road P.O. Box 335 Falkland BC V0E 1W0 (hereinafter “AVVAA”) OF THE FIRST PART AND: NATURES FORMULAE HEALTH PRODUCTS LTD. 132-1135 Stevens Road Kelowna, BC V1 |
|
| May 5, 2005 |
THIS AGREEMENT made as of the 6th day of May 2003 BETWEEN: AVVAA World Health Care Products a Company incorporated pursuant to the laws of the state of Nevada and having an office address located at 3018 Schaeffer Road, Falkland, British Columbia, V0E 1W0 (the ?Employer?) AND: Charles Austin 13503 Sumac Lane . |
|
| May 5, 2005 |
AVVAA WORLD HEALTH CARE PRODUCTS, INC. 2004 STOCK OPTION PLAN Effective June 1st, 2004 EX-4.2 6 fsb2ex42avvaa.htm 2004 STOCK OPTION PLAN 1 of 14 AVVAA WORLD HEALTH CARE PRODUCTS, INC. 2004 STOCK OPTION PLAN Effective June 1st, 2004 1. ARTICLE GENERAL PROVISIONS 1.1. PURPOSE OF THE PLAN This 2004 Stock Option Plan (the “Plan”) is intended to promote the interests of AVVAA World Health Care Products, Inc., a Nevada corporation (the “Corporation”), by providing eligible persons with th |
|
| May 5, 2005 |
CLASS D COMMON STOCK PURCHASE WARRANT EX-10.6 13 fsb2ex106avvaa.htm FORM OF CLASS D COMMON STOCK PURCHASE WARRANT THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION ST |
|
| May 5, 2005 |
BY-LAWS SIERRA GIGANTE RESOURCES INC. A Nevada Corporation ARTICLE I - OFFICES EX-3.(II) 4 fsb2ex3iiavvaa.htm BYLAWS BY-LAWS OF SIERRA GIGANTE RESOURCES INC. A Nevada Corporation ARTICLE I - OFFICES The registered office of the Corporation in the State of Nevada shall be located in the City and State designated in the Articles of Incorporation. The Corporation may also maintain offices at such other places within or without the State of Nevada as the Board of Directors may, |
|
| May 5, 2005 |
EX-3.(I) 3 fsb2ex3iavvaa.htm ARTICLES OF INCORPORATION ARTICLES OF INCORPORATION OF SIERRA GIGANTE RESOURCES, INC. The undersigned proposes to form a corporation under the laws of the State of Nevada, relating to private corporations, and to that end hereby adopt articles of incorporation as follows: ARTICLE ONE NAME The name of the corporation is SIERRA GIGANTE RESOURCES, INC. ARTICLE TWO LOCATIO |
|
| May 5, 2005 |
EX-10.1 8 fsb2ex101avvaa.htm SUBSCRIPTION AGREEMENT FOR $1,100,000 FINANCING SUBSCRIPTION AGREEMENT THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of April 5, 2005, by and among AVVAA World Health Care Products, Inc., a Nevada corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”). WHEREAS, the Company |
|
| April 19, 2005 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2005 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-26715 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of regi |
|
| April 14, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For Period Ended: February 28, 2005 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Tra |
|
| January 14, 2005 |
NT 10-Q 1 extf10qsb1104avvaa.htm FORM 10-QSB EXTENSION FOR PERIOD ENDING 11/04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: November 30, 2004 [ ] Transition Report on Form 10-K [ ] Transitio |
|
| August 30, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR [ ] Form N-CSR For Period Ended: May 31, 2004 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transiti |
|
| August 24, 2004 |
SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No. |
|
| August 12, 2004 |
EX-3.(I) 2 sc14cex3iavvaa.htm CERTIFICATE OF AMENDMENT FOR AVVAA DEAN HELLER Secretary of State 204 North Carson Street, Suite 1 Carson City, Nevada 89701-4299 (775) 684 5708 website: secretaryof state.biz Certificate of Amendment (Pursuant to NRS 78.385 and 78.390) Important: read attached instructions before completing form. Certificate of Amendment to Articles of Incorporation For Nevada Profit |
|
| August 12, 2004 |
SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14 (c) of the Securities Exchange Act of 1934 (Amendment No. |
|
| April 13, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: February 29, 2004 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report |
|
| January 22, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 2, 2004 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of Incorporation) 0-24262 (Commission |
|
| January 22, 2004 |
THIS AGREEMENT made as of the 1st day of August 2003 BETWEEN: AVVAA World Health Care Products a Company incorporated pursuant to the laws of the state of Nevada and having an office address located at 3018 Schaeffer Road, Falkland, British Columbia, V0E 1W0 (the "Employer") AND: Ron Reynolds Vernon, B. |
|
| January 22, 2004 |
THIS AGREEMENT MADE AS OF THE 15th DAY OF OCTOBER, 2003. BETWEEN: MIND YOUR OWN SKIN PRODUCTS INC. a Company incorporated pursuant to the laws of the Province of British Columbia being a wholly owned subsidiary of AVVAA WORLD HEALTH CARE PRODUCTS INC. a Company incorporated pursuant to the laws of the State of Nevada and each having an office address located at 3018 Schaeffer Road, Falkland, in th |
|
| January 22, 2004 |
1 ADDENDUM TO ASSET PURCHASE AGREEMENT This Addendum to Asset Purchase Agreement is made the 1st day of JANUARY, 2004. |
|
| January 14, 2004 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: November 30, 2003 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report |
|
| October 14, 2003 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: August 31, 2003 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on |
|
| August 29, 2003 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR For Period Ended: May 31, 2003 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Fo |
|
| August 29, 2003 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDED FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: 002432 10 2 (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR For Period Ended: May 31, 2003 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Tra |
|
| April 14, 2003 |
NT 10-Q 1 extf10qsbavvaa.htm EXTENSION FOR 3RD QUARTER REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR For Period Ended: February 28, 2003 [ ] Transition Report on Form 10-K [ ] Transition Report on Form |
|
| January 14, 2003 |
10QSB 1 f10qsb112002avvaa.htm QUARTERLY REPORT FOR NOVEMBER 30, 2002 f10q72002a2roanoke SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2002 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commis |
|
| January 14, 2003 |
EX-99.2 4 f10qsb112002cfoavvaa.htm CERTIFICATION OF CFO CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Charles Austin, certify that: 1. I have reviewed this quarterly report on Form 10-QSB of AVVAA World Health Care Products, Inc. 2. Based on my knowledge, this quarterly report does not contain an |
|
| January 14, 2003 |
EX-99.1 3 f10qsb112002ceoavvaa.htm CERTIFICATION OF CEO CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jack Farley, certify that: 1. I have reviewed this quarterly report on Form 10-QSB of AVVAA World Health Care Products, Inc. 2. Based on my knowledge, this quarterly report does not contain any u |
|
| December 2, 2002 |
Form S-8 CALCULATION OF REGISTRATION FEE SIGNATURES As filed with the Securities and Exchange Commission on December 2, 2002 Registration No. |
|
| December 2, 2002 |
THE 2002 BENEFIT PLAN OF THE 2002 BENEFIT PLAN OF AVVAA WORLD HEALTH PRODUCTS, INC. EX-4 3 fs8benefit2002ex4avvaa.htm THE 2002 BENEFIT PLAN THE 2002 BENEFIT PLAN OF THE 2002 BENEFIT PLAN OF AVVAA WORLD HEALTH PRODUCTS, INC. AVVAA World Health Products, Inc., a Nevada corporation (the "Company"), hereby adopts The 2002 Benefit Plan of AVVAA World Health Products, Inc. (the "Plan") this 25th day of November, 2002. Under the Plan, the Company may issue stock, or grant options to acq |
|
| October 15, 2002 |
EX-99.2 4 f10qsb82002cfoavvaa.htm CERTIFICATION FOR CFO CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Charles Austin, certify that: 1. I have reviewed this quarterly report on Form 10-QSB of AVVAA World Health Care Products, Inc. 2. Based on my knowledge, this quarterly report does not contain an |
|
| October 15, 2002 |
EX-99.1 3 f10qsb82002ceoavvaa.htm CERTIFICATION FOR CEO CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jack Farley, certify that: 1. I have reviewed this quarterly report on Form 10-QSB of AVVAA World Health Care Products, Inc. 2. Based on my knowledge, this quarterly report does not contain any u |
|
| October 15, 2002 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB |X| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2002 OR || TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-26715 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant |
|
| September 13, 2002 |
EX-99.2 4 certforcfoavvaa.htm CERTIFICATION OF CFO CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I Charles Austin certify that: 1. I have reviewed this annual report on Form 10-KSB of AVVAA World Health Care Products, Inc. 2. Based on my knowledge, this annual report does not contain any untrue stat |
|
| September 13, 2002 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-KSB ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended May 31, 2002 Commission File Number 0-31611 AVVAA WORLD HEALTH CARE PRODUCTS, INC. (Exact name of registrant as specified in its charter) Nevada 88-395714 (State or other jurisdiction of (I.R.S. Employer i |
|
| September 13, 2002 |
EX-99.1 3 certforceoavvaa.htm CERTIFICATION OF CEO CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I Jack Farley certify that: 1. I have reviewed this annual report on Form 10-KSB of AVVAA World Health Care Products, Inc. 2. Based on my knowledge, this annual report does not contain any untrue stateme |
|
| September 6, 2002 |
EX-99.2 4 f8kcertofcfoavvaa.htm CERTIFICATE OF CFO. CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THESARBANES-OXLEY ACT OF 2002 In connection with the Report of Form 8-K of AVVAA WORLD HEALTH CARE PRODUCTS, INC. (the “Company”) for the event reported June 28, 2002 as filed with the Securities and Exchange Commission on the date he |
|
| September 6, 2002 |
EX-99.1 3 f8kcertofceoavvaa.htm CERTIFICATE OF CEO. CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THESARBANES-OXLEY ACT OF 2002 In connection with the Report of Form 8-K of AVVAA WORLD HEALTH CARE PRODUCTS, INC. (the “Company”) for the event reported June 28, 2002 as filed with the Securities and Exchange Commission on the date he |
|
| September 6, 2002 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 28, 2002 AVVAA WORLD HEALTH CARE PRODUCTS INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of Incorporation) 000- |
|
| August 29, 2002 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER: 000-31611 CUSIP NUMBER: (Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR For Period Ended: May 31, 2002 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Fo |
|
| July 8, 2002 |
THIS SHARE EXCHANGE AND SHARE PURCHASE AGREEMENT is dated for reference the 28th day of June, 2002. |
|
| July 8, 2002 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 28, 2002 SIERRA GIGANTE RESOURCES, INC. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of Incorporation) - (Commission File Number) 88- |
